USA: CSRxP proposals call for drugmakers to make disclosures on drug prices

In the USA, the Campaign for Sustainable Rx Pricing (CSRxP), a diverse coalition of seniors, health plans and private companies, has set out proposals to address the cost of prescription drugs, from speeding the approval of generics to publicly reporting notable price hikes.

The CSRxP says taxpayers should get a full accounting of how much they are paying for high-cost drugs through federal programs like Medicare, or through research at the National Institutes of Health.

The coalition proposed requiring drugmakers to disclose a drug's unit price, the cost of a full course of treatment and a projection of federal spending on the drug. The coalition also suggested requiring drugmakers to release the true cost of research and development for a drug, as well as annually report increases in the drug's price.